The Motley Fool on MSN6d
Is Viking Therepautics a Buy Now?
The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.
Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...
So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...
Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...
JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today reported ...
Early screen time for young kids can set the stage for a sedentary life with an increased risk of obesity and heart disease.
The updated AAP clinical guidelines on obesity treatment recommend offering the full spectrum of care upon initial obesity ...
Shares of Viking Therapeutics, Inc. (VKTX) were gaining around 17 percent in the pre-market activity on the Nasdaq after the company ...
Related Vitamin D supplements during pregnancy linked to stronger bones in kids More learning in youth might not protect ...